Arik Moshe joined Neopharm Group in 1999. He served as the Group's CFO until 2005. In 2005, Arik was appointed CEO of Promedico and led the merger of Promedico into Neopharm Group, working to establish Promedico's position as a leading distribution and logistics company in the healthcare field. In 2009, he was appointed CEO of Neopharm Investments and head of the Group's finance, information systems and infrastructure functions.

Arik has extensive experience in managing operational systems, leading mergers and acquisitions, international activities, and large, complex projects at both the business and national level. Before joining Neopharm, Arik served in a variety of senior financial positions in the healthcare sector, including economic adviser to the Minister of Health, CEO of the Research and Development Fund of the Sourasky Medical Center, and board member of Magen David Adom Israel.

In his various roles, Arik led the planning and implementation of reforms in pharmaceutical and cosmetics markets, the establishment of a financial reporting system for Israel's HMOs, and more.

Arik holds a bachelor's degree in economics and accounting from Tel Aviv University. He is a certified public accountant.